Inotek to explore strategic options after eye drug fails trial

Published 9y ago

Inotek Pharmaceuticals Corp said on Friday it would evaluate strategic options after its sole experimental eye drug failed another trial, sending the company’s shares tumbling 45 percent in extended trading. More »